Vireo Growth Inc. (CSE:VREO)

Canada flag Canada · Delayed Price · Currency is CAD
14.84
-0.83 (-5.30%)
At close: Jun 22, 2026
Market Cap722.82M +166.7%
Revenue (ttm)489.21M +251.2%
Net Income-114.34M
EPS-3.76
Shares Out 46.13M
PE Ration/a
Forward PE11.18
Dividendn/a
Ex-Dividend Daten/a
Volume17,534
Open15.79
Previous Close15.67
Day's Range14.73 - 15.79
52-Week Range13.65 - 32.40
Beta0.01
Analystsn/a
Price Targetn/a
Earnings DateAug 7, 2026

About Vireo Growth

Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah. It sells cannabis products through a network of retail dispensaries and distributors. The company was formerly known as Goodness Growth Holdings, Inc. and changed its name to Vireo Growth Inc. in July 2024. Vireo Growth Inc. was incorporated in 2004 and is headquartered in Minneapolis, Minnesota. [Read more]

Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Founded 2004
Employees 612
Stock Exchange Canadian Securities Exchange
Ticker Symbol VREO
Full Company Profile

Financial Performance

In 2025, Vireo Growth's revenue was $268.77 million, an increase of 170.43% compared to the previous year's $99.38 million. Losses were -$68.11 million, 143.2% more than in 2024.

Financial numbers in USD Financial Statements

News

Vireo Growth Inc. Completes Acquisition of Equity Interest in Maryland Dispensaries

MINNEAPOLIS, June 18, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOD) (“Vireo” or the “Company”), today announced the closing of its previously announced acquisition to acquire a...

4 days ago - GlobeNewsWire

Vireo Growth Transcript: AGM 2026

The meeting confirmed quorum, approved all proposals including director elections, share consolidation, auditor appointment, and amendments to the CEO's agreement. All items passed by the required majority, with final results to be posted on regulatory platforms.

24 days ago - Transcripts

Vireo Growth Earnings Call Transcript: Q1 2026

Q1 2026 saw transformative acquisitions, driving a 333% year-over-year revenue increase and positioning the company as the fourth largest cannabis operator by revenue. Strong cash reserves, expanding state presence, and disciplined M&A support a positive outlook for 2026.

5 weeks ago - Transcripts

Vireo Growth Earnings release: Q1 2026

Vireo Growth released its Q1 2026 earnings on May 12, 2026, summarizing the period's financial results.

5 weeks ago - Filings

Vireo Growth Slides: Q1 2026

Vireo Growth has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 12, 2026.

5 weeks ago - Filings

Vireo Growth Earnings Call Transcript: Q4 2025

Q4 revenue surged 318% year-over-year, driven by acquisitions and strong organic growth, with same-store sales up 22% and adjusted EBITDA improving significantly. Major acquisitions and integration efforts expanded the footprint to 10 states, positioning for further scalable growth.

3 months ago - Transcripts

Vireo Growth Slides: Q4 2025

Vireo Growth has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 17, 2026.

3 months ago - Filings

Vireo Growth Earnings release: Q4 2025

Vireo Growth released its Q4 2025 earnings on March 17, 2026, summarizing the period's financial results.

3 months ago - Filings

Vireo Growth Earnings Call Transcript: Q3 2025

Q3 revenue surged 264% year-over-year, driven by recent M&A and organic growth, with adjusted EBITDA margin rising to 27.3%. Integration of acquisitions is on track, and the Schwazze deal expands the footprint to eight states. Strong cash position supports ongoing growth strategies.

7 months ago - Transcripts

Vireo Growth Earnings release: Q3 2025

Vireo Growth released its Q3 2025 earnings on November 12, 2025, summarizing the period's financial results.

7 months ago - Filings

Vireo Growth Slides: Q3 2025

Vireo Growth has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 12, 2025.

7 months ago - Filings

Vireo Growth Earnings Call Transcript: Q2 2025

Q2 revenue surged 91.4% year-over-year, driven by three mergers, with adjusted EBITDA margin at 25%. Post-quarter refinancing lowered annual interest expense by $10 million and boosted cash to over $100 million. Focus remains on organic growth, operational efficiency, and disciplined M&A.

11 months ago - Transcripts

Vireo Growth Slides: Q2 2025

Vireo Growth has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 13, 2025.

11 months ago - Filings

Vireo Growth Earnings release: Q2 2025

Vireo Growth released its Q2 2025 earnings on August 13, 2025, summarizing the period's financial results.

11 months ago - Filings